Thus, biologic drugs targeting inflammatory pathways, such as TNF-α and IL-6 signals, have been recommended to treat RA in combination with conventional synthetic drugs, and such combinations confer significantly better clinical efficacy than synthetic drugs alone [12]. This evidence concerns the gene TNF and rheumatoid arthritis.